FDA Approved: NEBIVOLOL — Supplemental Application (Apnar Pharma LP)

View source ↗

Summary

The FDA approved a supplemental application for nebivolol hydrochloride submitted by Apnar Pharma LP (ANDA216568).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Nebivolol hydrochloride (Nebivolol hydrochloride)

Snippet

SUPPL AP for NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE)